Search results for "Weight loss"


 
Results 1 - 10 of about 58 for "Weight loss".
Sort by: Relevance | Newest | Oldest

Guideline suggests prescription medications when lifestyle change ineffective for weight loss

For adults with obesity or overweight with weight-related complications, the American Gastroenterological Association found moderate certainty of benefit for four medications: semaglutide, liraglutide, phentermine-topiramate ER, or naltrexone-bupropion.
https://gastroenterology.acponline.org/archives/2022/10/28/6.htm
28 Oct 2022

RYGB associated with more alcohol-related hospitalizations than other weight-loss strategies

A recent cohort study compared hospitalizations related to alcohol use disorder and mortality among veterans who received Roux-en-Y gastric bypass (RYGB) surgery, sleeve gastrectomy, or referral to a weight management program.
https://gastroenterology.acponline.org/archives/2022/12/23/3.htm
23 Dec 2022

Phentermine-topiramate most effective drug for weight loss, meta-analysis finds

Among glucagon-like peptide-1 receptor agonists, semaglutide appeared to be the most effective for weight loss, with a higher likelihood of weight loss of 5% or more and percentage body weight change and a similar risk of adverse events.
https://gastroenterology.acponline.org/archives/2021/12/17/7.htm
17 Dec 2021

Food insecurity associated with less weight loss, even with intense intervention

The findings of a recent randomized trial suggest that weight loss approaches need to address both obesity and food insecurity, both of which continue to increase in the U.S.
https://gastroenterology.acponline.org/archives/2021/03/26/6.htm
26 Mar 2021

Recent-onset diabetes, weight loss associated with increased pancreatic cancer risk

Unintentional weight loss and weight loss in those with a body mass index already in the normal range were particularly associated with risk of pancreatic cancer among patients with recent-onset diabetes, a study found.
https://gastroenterology.acponline.org/archives/2020/09/25/6.htm
25 Sep 2020

Postapproval studies find risks of gastric balloon devices used for weight loss

A small number of patients experienced balloon hyperinflation and acute pancreatitis with the Orbera and ReShape liquid-filled intragastric balloons.
https://gastroenterology.acponline.org/archives/2020/05/22/8.htm
22 May 2020

FDA requests withdrawal of weight-loss drug from U.S. market

The manufacturer of lorcaserin will voluntarily withdraw the drug because a safety clinical trial showed that the drug was associated with an increased occurrence of cancer compared to placebo.
https://gastroenterology.acponline.org/archives/2020/02/28/6.htm
28 Feb 2020

Weight loss through gastric bypass or diet improved insulin sensitivity in patients with type 2 diabetes

Results from this small study suggest that reducing adipose tissue volume, by whatever means, will improve blood glucose control in patients with type 2 diabetes, an accompanying editorial noted.
https://gastroenterology.acponline.org/archives/2020/09/25/7.htm
25 Sep 2020

Weight loss interventions may improve biomarkers of liver disease in NAFLD

In a meta-analysis of 22 studies in patients with nonalcoholic fatty liver disease (NAFLD), weight loss interventions were associated with improvements in alanine aminotransferase level, liver steatosis, histologic NAFLD activity score, and nonalcoholic steatohepatitis.
https://gastroenterology.acponline.org/archives/2019/07/26/3.htm
26 Jul 2019

More patient deaths associated with intragastric balloon weight-loss systems

Clinicians should closely monitor patients with intragastric balloons for complications and explain symptoms that could be signs of serious or life-threatening problems, the FDA advised.
https://gastroenterology.acponline.org/archives/2018/06/22/7.htm
22 Jun 2018

Result Page: Prev   1   2   3   4   5   6   Next